Literature DB >> 23277747

Cost-effectiveness analysis of a system-based approach for managing neonatal jaundice and preventing kernicterus in Ontario.

Bin Xie1, Orlando da Silva, Greg Zaric.   

Abstract

OBJECTIVE: To evaluate the incremental cost-effectiveness of a system-based approach for the management of neonatal jaundice and the prevention of kernicterus in term and late-preterm (≥35 weeks) infants, compared with the traditional practice based on visual inspection and selected bilirubin testing. STUDY
DESIGN: Two hypothetical cohorts of 150,000 term and late-preterm neonates were used to compare the costs and outcomes associated with the use of a system-based or traditional practice approach. Data for the evaluation were obtained from the case costing centre at a large teaching hospital in Ontario, supplemented by data from the literature.
RESULTS: The per child cost for the system-based approach cohort was $176, compared with $173 in the traditional practice cohort. The higher cost associated with the system-based cohort reflects increased costs for predischarge screening and treatment and increased postdischarge follow-up visits. These costs are partially offset by reduced costs from fewer emergency room visits, hospital readmissions and kernicterus cases. Compared with the traditional approach, the cost to prevent one kernicterus case using the system-based approach was $570,496, the cost per life year gained was $26,279, and the cost per quality-adjusted life year gained was $65,698.
CONCLUSION: The cost to prevent one kernicterus case using the system-based approach is much lower than previously reported in the literature.

Entities:  

Keywords:  Comparative effectiveness research; Jaundice; Kernicterus; Neonatology

Year:  2012        PMID: 23277747      PMCID: PMC3276518          DOI: 10.1093/pch/17.1.11

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  30 in total

1.  Effect of publication of the "Practice Parameter for the management of hyperbilirubinemia" on treatment of neonatal jaundice.

Authors:  D S Seidman; I Paz; Y Armon; Z Ergaz; D K Stevenson; R Gale
Journal:  Acta Paediatr       Date:  2001-03       Impact factor: 2.299

2.  System-based approach to management of neonatal jaundice and prevention of kernicterus.

Authors:  Lois H Johnson; Vinod K Bhutani; Audrey K Brown
Journal:  J Pediatr       Date:  2002-04       Impact factor: 4.406

3.  Incidence, course, and prediction of hyperbilirubinemia in near-term and term newborns.

Authors:  S Umit Sarici; Muhittin A Serdar; Ayse Korkmaz; Gülsen Erdem; Olcay Oran; Gülsevin Tekinalp; Murat Yurdakök; Sule Yigit
Journal:  Pediatrics       Date:  2004-04       Impact factor: 7.124

4.  Reduction of severe hyperbilirubinemia after institution of predischarge bilirubin screening.

Authors:  Michael P Mah; Steven L Clark; Efe Akhigbe; Jane Englebright; Donna K Frye; Janet A Meyers; Jonathan B Perlin; Mitch Rodriguez; Arthur Shepard
Journal:  Pediatrics       Date:  2010-04-05       Impact factor: 7.124

5.  Who will deliver our grandchildren? Implications of cerebral palsy litigation.

Authors:  Alastair MacLennan; Karin B Nelson; Gary Hankins; Michael Speer
Journal:  JAMA       Date:  2005-10-05       Impact factor: 56.272

6.  The cost-effectiveness of prenatal screening for spinal muscular atrophy.

Authors:  Sarah E Little; Vanitha Janakiraman; Anjali Kaimal; Thomas Musci; Jeffrey Ecker; Aaron B Caughey
Journal:  Am J Obstet Gynecol       Date:  2010-03       Impact factor: 8.661

7.  Prospective study of the patient-level cost of asthma care in children.

Authors:  W J Ungar; P C Coyte
Journal:  Pediatr Pulmonol       Date:  2001-08

8.  Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment--United States, 2003.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2004-01-30       Impact factor: 17.586

9.  Cost-effectiveness of intrathecal baclofen therapy for the treatment of severe spasticity associated with cerebral palsy.

Authors:  Gregory de Lissovoy; Louis S Matza; Hannah Green; Meghan Werner; Terence Edgar
Journal:  J Child Neurol       Date:  2007-01       Impact factor: 1.987

10.  Predictive ability of a predischarge hour-specific serum bilirubin for subsequent significant hyperbilirubinemia in healthy term and near-term newborns.

Authors:  V K Bhutani; L Johnson; E M Sivieri
Journal:  Pediatrics       Date:  1999-01       Impact factor: 7.124

View more
  1 in total

1.  Cost savings with transcutaneous screening versus total serum bilirubin measurement for newborn jaundice in hospital and community settings: a cost-minimization analysis.

Authors:  Stephanie McClean; Krista Baerg; Julie Smith-Fehr; Michael Szafron
Journal:  CMAJ Open       Date:  2018-07-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.